NLS Global report

Collaboration - January 27, 2026

Philanthropic partners invest USD 60 million to counter the AMR crisis

The Gates Foundation, Novo Nordisk Foundation, and Wellcome has awarded a new grant funding over the next three years to research teams around the world exploring novel approaches to antibiotic discovery to deal with the growing threat of antimicrobial resistance (AMR).

Global report - January 21, 2026

New report: Unlocking investment in women’s health

Women’s health only receives 6% of private healthcare investment despite women representing almost half of the global population, according to a new World Economic Forum report, launched January 20 2026.

Global report - January 18, 2026

Trump announces new tariffs against Europe

In a post on Truth Social, US President Trump said additional 10% import tariffs would take effect on February 1, 2026 on goods from Denmark, Norway, Sweden, France, Germany, the Netherlands, Finland and Great Britain. Those tariffs would increase to 25% on June 1, 2026 and would continue until a deal was reached for the […]

Business article - January 14, 2026

JPM 2026: Top Four Business Highlights

This year's JPM business announces include an oncology deal, obesity and radioligand race positioning, and an AI alliance.

Global report - January 14, 2026

AstraZeneca acquires Modella AI

AstraZeneca is acquiring its AI partner Modella AI to own and deploy multimodal AI foundation models in‑house across discovery and development.

Acquisition - January 13, 2026

Novartis buys radioligand peptide program from PepLib 

Novartis agreed to pay USD 50 million in cash upfront (plus undisclosed milestones) for a peptide‑based radioligand oncology program from Zonsen PepLib Biotech.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.